AiCure builds and deploys clinically-validated artificial intelligence technologies to optimize patient behavior and medication adherence. The company was founded in 2010 to revolutionize patient monitoring with the ultimate goal of reducing hospitalizations and extending life expectancy.
The AiCure solution is differentiated through science and scale
Adherence validated against blood levels
Funded by the National Institutes of Health
A patented artificial intelligence foundation
Technology that can be accessed by billions of smartphone users worldwide
Entering a new era of visual diagnostics
AiCure is developing an advanced patented mobile technology platform by combining the most recent advances in Artificial Intelligence through deep learning, computer vision, machine learning and predictive analytics. Through technology, AiCure is bringing continuity of care to patients throughout the world, ultimately democratizing care for all.